Literature DB >> 32156696

Clinical features and management of children with primary ciliary dyskinesia in England.

Bruna Rubbo1,2, Sunayna Best3, Robert Anthony Hirst4, Amelia Shoemark3, Patricia Goggin1,2, Siobhan B Carr3,5, Philip Chetcuti6, Claire Hogg3,5, Priti Kenia7, Jane S Lucas2, Eduardo Moya8, Manjith Narayanan4,9, Christopher O'Callaghan9,10, Michael Williamson9, Woolf Theodore Walker11.   

Abstract

OBJECTIVE: In England, the National Health Service commissioned a National Management Service for children with primary ciliary dyskinesia (PCD). The aims of this study were to describe the health of children seen in this Service and compare lung function to children with cystic fibrosis (CF).
DESIGN: Multi-centre service evaluation of the English National Management PCD Service.
SETTING: Four nationally commissioned PCD centres in England. PATIENTS: 333 children with PCD reviewed in the Service in 2015; lung function data were also compared with 2970 children with CF.
RESULTS: Median age at diagnosis for PCD was 2.6 years, significantly lower in children with situs inversus (1.0 vs 6.0 years, p<0.001). Compared with national data from the CF Registry, mean (SD) %predicted forced expiratory volume in one second (FEV1) was 76.8% in PCD (n=240) and 85.0% in CF, and FEV1 was lower in children with PCD up to the age of 15 years. Approximately half of children had some hearing impairment, with 26% requiring hearing aids. Children with a lower body mass index (BMI) had lower FEV1 (p<0.001). One-third of children had positive respiratory cultures at review, 54% of these grew Haemophilus influenzae.
CONCLUSIONS: We provide evidence that children with PCD in England have worse lung function than those with CF. Nutritional status should be considered in PCD management, as those with a lower BMI have significantly lower FEV1. Hearing impairment is common but seems to improve with age. Well-designed and powered randomised controlled trials on management of PCD are needed to inform best clinical practice. © Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  cystic Fibrosis; lung function; management; primary ciliary dyskinesia

Year:  2020        PMID: 32156696     DOI: 10.1136/archdischild-2019-317687

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  7 in total

1.  SARS-CoV-2 infections in people with primary ciliary dyskinesia: neither frequent, nor particularly severe.

Authors:  Eva S L Pedersen; Myrofora Goutaki; Amanda L Harris; Lucy Dixon; Michele Manion; Bernhard Rindlisbacher; Covid-Pcd Patient Advisory Group; Jane S Lucas; Claudia E Kuehni
Journal:  Eur Respir J       Date:  2021-08-05       Impact factor: 16.671

2.  COVID-PCD: a participatory research study on the impact of COVID-19 in people with primary ciliary dyskinesia.

Authors:  Eva S L Pedersen; Eugénie N R Collaud; Rebeca Mozun; Cristina Ardura-Garcia; Yin Ting Lam; Amanda Harris; Jane S Lucas; Fiona Copeland; Michele Manion; Bernhard Rindlisbacher; Hansruedi Silberschmidt; Myrofora Goutaki; Claudia E Kuehni
Journal:  ERJ Open Res       Date:  2021-03-22

3.  Facemask Usage Among People With Primary Ciliary Dyskinesia During the COVID-19 Pandemic: A Participatory Project.

Authors:  Eva S L Pedersen; Eugenie N R Collaud; Rebeca Mozun; Katie Dexter; Catherine Kruljac; Hansruedi Silberschmidt; Jane S Lucas; Myrofora Goutaki; Claudia E Kuehni
Journal:  Int J Public Health       Date:  2021-12-15       Impact factor: 3.380

4.  COVID-19 Vaccinations: Perceptions and Behaviours in People with Primary Ciliary Dyskinesia.

Authors:  Eva S L Pedersen; Maria Christina Mallet; Yin Ting Lam; Sara Bellu; Isabelle Cizeau; Fiona Copeland; Trini Lopez Fernandez; Michele Manion; Amanda L Harris; Jane S Lucas; Francesca Santamaria; Myrofora Goutaki; Claudia E Kuehni
Journal:  Vaccines (Basel)       Date:  2021-12-17

Review 5.  Chronic airway disease in primary ciliary dyskinesia-spiced with geno-phenotype associations.

Authors:  Kim G Nielsen; Mathias G Holgersen; Suzanne Crowley; June K Marthin
Journal:  Am J Med Genet C Semin Med Genet       Date:  2022-03-29       Impact factor: 3.359

6.  Long-Term Azithromycin Treatment in Pediatric Primary Ciliary Dyskinesia: A Retrospective Study.

Authors:  Yuhong Guan; Xiang Zhang; Haiming Yang; Hui Xu; Shunying Zhao
Journal:  Front Pediatr       Date:  2022-06-10       Impact factor: 3.569

7.  The Impact on Parents of Diagnosing PCD in Young Children.

Authors:  Corine Driessens; Siobhan Carr; Edel Clough; Fiona Copeland; Sharon Dell; Lucy Dixon; Amanda Harris; Rebecca Knibb; Margaret Leigh; Manjith Narayanan; Beatrice Redfern; Evie Robson; Michael Sawras; Lynne Schofield; Kelli Sullivan; Myra Tipping; Nhu Tran; Woolf Walker; Jane S Lucas; Laura Behan
Journal:  J Clin Med       Date:  2022-08-16       Impact factor: 4.964

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.